COMMUNIQUÉS West-GlobeNewswire

RespireRx Pharmaceuticals Inc. Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea

30/11/2017 - 14:45

Glen Rock, N.J, Nov. 30, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”) announces that the results of the PACE (Pharmacotherapy of Apnea by Cannabimimetic [...]

PDMR Dealing

30/11/2017 - 14:42

LONDON, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing

30/11/2017 - 14:41

BETHLEHEM, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced several new HIV testing-related [...]

Industry Veteran Dr. Meqsood Rehman Promoted to Chief Executive Officer of Gala Global Inc.

30/11/2017 - 14:36

ORANGE COUNTY, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTCBB: GLAG ) today announced that it has promoted Dr. Meqsood Rehman, 41, to the Chief Executive Officer of Gala Global, Inc., taking over [...]

SeaSpine Announces FDA 510(k) Clearance of OsteoBallast™ Demineralized Bone Matrix in Resorbable Mesh

30/11/2017 - 14:30

CARLSBAD, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]

Ultragenyx to Highlight Pipeline at Analyst and Investor Day on December 4

30/11/2017 - 14:30

NOVATO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, announced [...]

Targovax ASA: New member of the board of directors

30/11/2017 - 14:04

Oslo, Norway, 30 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the extraordinary general meeting of Targovax [...]

Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors

30/11/2017 - 14:01

HAMPTON, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq: CLDX ) announced today that enrollment has opened in its open-label, Phase 1 study of CDX-1140 in patients with advanced solid tumors [...]

Achaogen to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference

30/11/2017 - 14:01

SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]

Cancer Genetics to Participate in Upcoming Investor Conferences

30/11/2017 - 14:00

RUTHERFORD, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that the [...]

BIOLIFE4D Selects FischTank Marketing and PR as Agency of Record

30/11/2017 - 14:00

CHICAGO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has retained FischTank Marketing and [...]

Hooper Holmes Inc. to Present at the LD Micro 10th Annual Main Event on December 5, 2017

30/11/2017 - 14:00

OLATHE, Kan., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. (OTCQX:HPHW) today announced that, Henry Dubois, Chief Executive Officer, and Mark Clermont, President, will be featured presenters at the LD Micro 10 [...]

Portola Pharmaceuticals to Present New Data on Betrixaban, Andexanet Alfa and Cerdulatinib at the 59th American Society of Hematology (ASH) Annual Meeting

30/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that new data on the Company’s first FDA-approved anticoagulant, betrixaban, and its two [...]

HempAmericana Inc. Executes Lease for High-Capacity CBD Oil Production Facility Site in Maine; Two-year Lease on Massive 17k Sq Ft Permit-Ready Facility Commences December 1

30/11/2017 - 14:00

NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is excited to announce that the Company has fully executed the lease for a 17,000-square foot state-of-the-art facility in [...]

Final Patient Completes Treatment in Innovation Pharmaceuticals Phase 2b Study of Oral Prurisol for Psoriasis

30/11/2017 - 14:00

BEVERLY, Mass., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc., (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces that the last patient has completed study [...]

New Publication Summarizes Phase 1 Studies of CK-2127107 Showing Tolerability and Amplification of Skeletal Muscle Response to Nerve Activation

30/11/2017 - 13:30

Next Generation Fast Skeletal Muscle Activator Appears Promising Compared to Tirasemtiv in Studies of Healthy Volunteers SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq [...]

Cesca Therapeutics Inc. to Participate in the LD Micro 10th Annual Main Event on Thursday, December 7, 2017

30/11/2017 - 13:30

RANCHO CORDOVA, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]

New Publication Shows Respiratory Decline Correlated With Disease Progression in People Living With ALS

30/11/2017 - 13:30

Retrospective Analyses of Clinical Trials in ALS Shows Faster Rate of Decline in Slow Vital Capacity Strongly Predicts Increased Risk of Future Clinical Events SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE [...]

Industry Veteran Dr. Maqsood Rehman Promoted to Chief Executive Officer of Gala Global Inc.; Company Strengthens Senior Management Team as it Repositions Company’s Growth Strategy

30/11/2017 - 13:00

ANAHEIM, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTC Pink:GLAG) today announced that it has promoted Dr. Maqsood Rehman, to the Chief Executive Officer of Gala Global, Inc., taking over from Timothy [...]